ORIGINAL RESEARCH
Accepted on 31 Jan 2025
β-lapachone Suppresses Carcinogenesis of Cervical Cancer via Interaction with AKT1
doi 10.3389/fphar.2025.1509568
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Metabolic reprogramming in cancer
Metabolic reprogramming in cancer
7,251
Total downloads
21k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 17 Oct 2024
Cancer metabolic reprogramming and precision medicine-current perspective
doi 10.3389/fphar.2024.1450441
- 647 views
ORIGINAL RESEARCH
Published on 08 Aug 2024
The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells
doi 10.3389/fphar.2024.1422281
- 836 views
REVIEW
Published on 25 Jul 2024
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
doi 10.3389/fimmu.2024.1353787
- 3,629 views
- 2 citations
SYSTEMATIC REVIEW
Published on 16 Jul 2024
Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023
doi 10.3389/fphar.2024.1392241
- 1,540 views
- 1 citation
REVIEW
Published on 27 Jun 2024
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
doi 10.3389/fphar.2024.1367981
- 1,117 views
MINI REVIEW
Published on 26 Jun 2024
Metabolic reprogramming in esophageal squamous cell carcinoma
doi 10.3389/fphar.2024.1423629
- 1,122 views
REVIEW
Published on 31 May 2024
The role of metabolic reprogramming in kidney cancer
doi 10.3389/fonc.2024.1402351
- 1,172 views
ORIGINAL RESEARCH
Published on 27 May 2024
The value of plasma omega-3 polyunsaturated fatty acids in predicting the response and prognosis of cervical squamous cell carcinoma patients to concurrent chemoradiotherapy
doi 10.3389/fphar.2024.1379508
- 1,063 views
ORIGINAL RESEARCH
Published on 07 Mar 2024
Identification and validation of prognostic and immunotherapeutic responses in esophageal squamous carcinoma based on hypoxia phenotype-related genes
doi 10.3389/fphar.2024.1344317
- 993 views
REVIEW
Published on 20 Feb 2024
Targeting SHMTs and MTHFDs in cancer: attractive opportunity for anti-tumor strategy
doi 10.3389/fphar.2024.1335785
- 1,087 views
- 1 citation
REVIEW
Published on 11 Jan 2024
Ferroptosis: a dual-edged sword in tumour growth
doi 10.3389/fphar.2023.1330910
- 1,102 views
- 3 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 21kTopic views
- 12kArticle views
- 7,251Article downloads